These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 29706503)
1. Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy. Sonpavde G; Pond GR; Rosenberg JE; Choueiri TK; Bellmunt J; Regazzi AM; Mullane SA; Necchi A; Raggi D; Lee JL; Lee S; Simpson J; Derleth CL; Lin SW; Bajorin DF Clin Genitourin Cancer; 2018 Aug; 16(4):e961-e967. PubMed ID: 29706503 [TBL] [Abstract][Full Text] [Related]
2. Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC). Necchi A; Sonpavde G; Lo Vullo S; Giardiello D; Bamias A; Crabb SJ; Harshman LC; Bellmunt J; De Giorgi U; Sternberg CN; Cerbone L; Ladoire S; Wong YN; Yu EY; Chowdhury S; Niegisch G; Srinivas S; Vaishampayan UN; Pal SK; Agarwal N; Alva A; Baniel J; Golshayan AR; Morales-Barrera R; Bowles DW; Milowsky MI; Theodore C; Berthold DR; Daugaard G; Sridhar SS; Powles T; Rosenberg JE; Galsky MD; Mariani L; Eur Urol; 2017 Feb; 71(2):281-289. PubMed ID: 27726966 [TBL] [Abstract][Full Text] [Related]
3. Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy. Galsky MD; Moshier E; Krege S; Lin CC; Hahn N; Ecke T; Sonpavde G; Godbold J; Oh WK; Bamias A Cancer; 2013 Aug; 119(16):3012-9. PubMed ID: 23720216 [TBL] [Abstract][Full Text] [Related]
4. A Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial Carcinoma. Kim YS; Lee SI; Park SH; Park S; Hwang IG; Lee SC; Sun JM; Lee J; Lim HY Clin Genitourin Cancer; 2016 Feb; 14(1):76-81. PubMed ID: 26454620 [TBL] [Abstract][Full Text] [Related]
5. A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma. Pond GR; Agarwal N; Bellmunt J; Choueiri TK; Qu A; Fougeray R; Vaughn D; James ND; Salhi Y; Albers P; Niegisch G; Galsky MD; Wong YN; Ko YJ; Stadler WM; O'Donnell PH; Sridhar SS; Vogelzang NJ; Necchi A; Di Lorenzo G; Sternberg CN; Mehta A; Sonpavde G BJU Int; 2014 May; 113(5b):E137-43. PubMed ID: 24219029 [TBL] [Abstract][Full Text] [Related]
11. Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma. Motzer RJ; Bukowski RM; Figlin RA; Hutson TE; Michaelson MD; Kim ST; Baum CM; Kattan MW Cancer; 2008 Oct; 113(7):1552-8. PubMed ID: 18720362 [TBL] [Abstract][Full Text] [Related]
12. Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma. Sonpavde G; Pond GR; Choueiri TK; Mullane S; Niegisch G; Albers P; Necchi A; Di Lorenzo G; Buonerba C; Rozzi A; Matsumoto K; Lee JL; Kitamura H; Kume H; Bellmunt J Eur Urol; 2016 Apr; 69(4):634-641. PubMed ID: 26264159 [TBL] [Abstract][Full Text] [Related]
13. Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Clinical Experience from an Expanded Access Study in the United States. Pal SK; Hoffman-Censits J; Zheng H; Kaiser C; Tayama D; Bellmunt J Eur Urol; 2018 May; 73(5):800-806. PubMed ID: 29478735 [TBL] [Abstract][Full Text] [Related]
14. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder. Al-Daghmin A; English S; Kauffman EC; Din R; Khan A; Syed JR; Sztorc J; Mehedint D; Sharif M; Shi Y; Wilding G; Guru KA BJU Int; 2014 Aug; 114(2):253-60. PubMed ID: 24119175 [TBL] [Abstract][Full Text] [Related]
15. Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic Model. Salah S; Lee JL; Rozzi A; Kitamura H; Matsumoto K; Srinivas S; Morales-Barrera R; Carles J; Al-Wardat R; Al-Rabi K; Maakoseh M Clin Genitourin Cancer; 2016 Jun; 14(3):255-60. PubMed ID: 26552764 [TBL] [Abstract][Full Text] [Related]
16. Docetaxel for the treatment of bladder cancer. Albany C; Sonpavde G Expert Opin Investig Drugs; 2015; 24(12):1657-64. PubMed ID: 26535615 [TBL] [Abstract][Full Text] [Related]